Here’s what you should know:
1. Dr. Reeves was recognized for his high level of training and experience with NeoTract’s UroLift System. He uses the system to treat symptoms associated with benign prostatic hyperplasia.
2. The UroLift system is intended to provide BPH patients relief. According to randomized study data, patients treated with the UroLift system experienced symptom relief with minimal side effects, the press release notes.
3. Dr. Reeves said, “I am proud to be a national leader in treating patients with this durable and effective treatment.”
More articles on leadership:
5 takeaways from ACG’s new Crohn’s disease recommendations
5 most-read GI/endoscopy stories: July 26-August 1
Entyvio drives Takeda’s Q1 revenue growth: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.